Qube Research & Technologies (QRT)
MURA

Qube Research & Technologies (QRT)’s Mural Oncology MURA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,465
Closed -$35.9K – 3705
2024
Q3 		$35.9K Sell
11,465
-37,238
-76% -$121K ﹤0.01% 2910
2024
Q2 		$153K Buy
48,703
+40,983
+531% +$151K ﹤0.01% 2508
2024
Q1 		$37.8K Sell
7,720
-18,009
-70% -$87.4K ﹤0.01% 3573
2023
Q4 		$152K Buy
+25,729
New +$103K ﹤0.01% 2937

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MURA Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Mural Oncology (MURA) in Q4 2024, closing a stake of 11,465 shares — an estimated $35.9K sold.

Qube Research & Technologies (QRT) first reported a position in MURA in Q4 2023 and held it in 4 quarters. The position peaked at $153K in Q2 2024. 76 funds tracked by Wall St. Rank hold MURA as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Mural Oncology position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 11,465 Mural Oncology shares in Q4 2024, an estimated $35.9K.
  • Qube Research & Technologies (QRT) first reported a position in Mural Oncology in Q4 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Mural Oncology position peaked at $153K in Q2 2024.
  • 76 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.